Filing Details

Accession Number:
0000899243-22-028978
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-17 16:15:13
Reporting Period:
2022-08-15
Accepted Time:
2022-08-17 16:15:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1805387 Cerevel Therapeutics Holdings Inc. CERE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1722140 Abraham Ceesay C/O Cerevel Therapeutics Holdings, Inc.
222 Jacobs Street, Suite 200
Cambridge MA 02141
President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-08-15 9,606 $13.17 9,606 No 4 M Direct
Common Stock Disposition 2022-08-15 9,606 $34.12 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2022-08-15 9,606 $0.00 9,606 $13.17
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
393,824 2031-06-01 No 4 M Direct
Footnotes
  1. These transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 17, 2022 adopted by the Reporting Person.
  2. 25% of the shares subject to this option vested and became exercisable on June 1, 2022, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.